Suprapapillary Metal Stent vs. Routine Transpapillary Drainage in Malignant Hilar Biliary Obstruction (SMART-B Trial)
- Sponsor
- Hospital de Clinicas de Porto Alegre
- Study ID
- NCT07558304
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bile Duct Neoplasms
- Cholangiocarcinoma
- Malignant Biliary Obstruction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Percutaneous transpapillary internal-external biliary drainage — PROCEDUREPercutaneous biliary drainage performed by advancing a catheter across the biliary obstruction and through the papilla into the duodenum, allowing internal and external bile drainage.
- Percutaneous suprapapillary biliary drainage with self-expanding metal stent — PROCEDUREPercutaneous biliary drainage performed by placing a self-expanding metal stent across the biliary obstruction without crossing the papilla.
Study Details
Malignant hilar biliary obstruction is a condition in which the bile ducts near the liver become blocked due to cancer. This blockage can lead to jaundice (yellowing of the skin and eyes), itching, infection, and impaired liver function. To relieve the obstruction, doctors commonly perform procedures to drain bile and restore its flow. There are different techniques available for biliary drainage. One common method is percutaneous transpapillary internal-external drainage, in which a catheter is placed through the liver and across the natural opening of the bile duct into the intestine. Another approach is percutaneous suprapapillary drainage using a self-expanding metal stent, which allows bile to drain without crossing into the intestine and may reduce the risk of contamination and infection. Currently, there is no clear consensus on which of these two techniques is safer or more effective for patients with malignant proximal biliary obstruction. Some studies suggest that avoiding manipulation of the intestinal opening of the bile duct may reduce complications such as infection, but high-quality comparative evidence is lacking. The purpose of this study is to compare percutaneous suprapapillary drainage with a self-expanding metal stent versus routine percutaneous transpapillary internal-external drainage in patients with malignant proximal biliary obstruction. The study aims to compare the rate of drainage-related complications between the two techniques, as well as to evaluate treatment success, stent patency, and the need for reintervention. In addition, in patients with potentially resectable disease undergoing preoperative biliary drainage, the study will assess and compare surgical outcomes between the two approaches. The results of this study may help determine the safest and most effective drainage strategy for these patients and improve future clinical decision-making.
Key Dates
- First listed
- Apr 30, 2026
- Start date
- Jun 15, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 84 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Transpapillary internal-external drainageParticipants undergo percutaneous transpapillary internal-external biliary drainage with placement of a catheter across the obstruction and through the papilla into the duodenum, according to standard institutional practice.
- Active Comparator: Suprapapillary Self-Expanding Metal Stent DrainageParticipants undergo percutaneous suprapapillary biliary drainage with placement of a self-expanding metal stent across the obstruction without crossing the papilla.
Primary Outcome Measure
Acute cholangitis [ Time Frame: Within 90 days after intervention ]
Central Contacts
- Cleber R. P. Kruel, Professor+55(51)3359-8232
- Gabriel L. da Silva, Attending Physician+55(51)3359-8232
Related Studies
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Biobank for Cholestatic Liver Diseases.Recruiting · Mayo Clinic · Rochester, Minnesota
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursPHASE1/PHASE2 · Recruiting · Bold Therapeutics, Inc. · Santa Monica, California